Literature DB >> 7758954

Identification of a duplication of the mouse Lyn gene.

M L Hibbs1, E Stanley, R Maglitto, A R Dunn.   

Abstract

The Lyn gene encodes a PTK that is believed to participate in the transduction of signals from a variety of cell membrane receptors. Here we report the genomic organisation of the mouse Lyn gene and show that, while the promoter and exons 11-13 are present in single copy, sequences corresponding to the first coding exon are duplicated and this duplication extends into intron 10. Two sets of genomic clones representing the duplicated regions have been isolated and characterised. Nucleotide sequence analysis of these clones has revealed minimal sequence divergence between the two, suggesting that the duplication is a recent event. This is supported by Southern blot analysis of DNA from other mammalian species showing that the duplication is confined to the mouse. Aside from the duplicated sequences, the overall structure of the mouse Lyn gene is similar to that of other Src family members. These data suggest that the process of duplication which generated the Src family of PTK is an ongoing process and provide an insight into the molecular evolution of this group of genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758954     DOI: 10.1016/0378-1119(95)00022-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Targeting Lyn regulates Snail family shuttling and inhibits metastasis.

Authors:  D Thaper; S Vahid; K M Nip; I Moskalev; X Shan; S Frees; M E Roberts; K Ketola; K W Harder; C Gregory-Evans; J L Bishop; A Zoubeidi
Journal:  Oncogene       Date:  2017-03-13       Impact factor: 9.867

2.  Functions of the Lyn tyrosine kinase in health and disease.

Authors:  Evan Ingley
Journal:  Cell Commun Signal       Date:  2012-07-17       Impact factor: 5.712

Review 3.  Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity.

Authors:  Erica J Brodie; Simona Infantino; Michael S Y Low; David M Tarlinton
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.